DCN expression was mainly found in fibroblast-like cells and in the matrix in the bone metastasis stroma and the current study suggests that reduced synthesis of DCN may contribute to the growth of the most aggressive bone metastases (Ki67 high, PSA low, MetB). The gene discussed is KLK3; the disease is bone metastasis.